A detailed history of State Of Alaska, Department Of Revenue transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 26,323 shares of PCRX stock, worth $543,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,323
Previous 27,328 3.68%
Holding current value
$543,306
Previous $781,000 49.3%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$11.7 - $28.46 $11,758 - $28,602
-1,005 Reduced 3.68%
26,323 $396,000
Q2 2024

Aug 05, 2024

SELL
$25.5 - $31.51 $24,531 - $30,312
-962 Reduced 3.4%
27,328 $781,000
Q1 2024

Apr 19, 2024

SELL
$27.7 - $35.48 $7,728 - $9,898
-279 Reduced 0.98%
28,290 $826,000
Q4 2023

Jan 19, 2024

SELL
$26.32 - $34.31 $9,159 - $11,939
-348 Reduced 1.2%
28,569 $963,000
Q3 2023

Oct 16, 2023

SELL
$30.68 - $40.09 $41,203 - $53,840
-1,343 Reduced 4.44%
28,917 $887,000
Q2 2023

Jul 24, 2023

SELL
$36.12 - $47.5 $41,863 - $55,052
-1,159 Reduced 3.69%
30,260 $1.21 Million
Q1 2023

Apr 17, 2023

SELL
$35.53 - $43.38 $18,511 - $22,600
-521 Reduced 1.63%
31,419 $1.28 Million
Q4 2022

Jan 11, 2023

BUY
$38.19 - $57.45 $8,210 - $12,351
215 Added 0.68%
31,940 $1.23 Million
Q3 2022

Oct 20, 2022

SELL
$51.24 - $58.89 $135,119 - $155,292
-2,637 Reduced 7.67%
31,725 $1.69 Million
Q2 2022

Jul 08, 2022

BUY
$51.49 - $81.64 $169,402 - $268,595
3,290 Added 10.59%
34,362 $2 Million
Q1 2022

Apr 14, 2022

SELL
$60.03 - $76.49 $28,214 - $35,950
-470 Reduced 1.49%
31,072 $2.37 Million
Q4 2021

Jan 12, 2022

SELL
$47.97 - $62.21 $42,453 - $55,055
-885 Reduced 2.73%
31,542 $1.9 Million
Q3 2021

Oct 07, 2021

BUY
$54.64 - $61.3 $107,367 - $120,454
1,965 Added 6.45%
32,427 $1.82 Million
Q2 2021

Jul 12, 2021

BUY
$59.18 - $69.99 $45,686 - $54,032
772 Added 2.6%
30,462 $1.85 Million
Q1 2021

Apr 09, 2021

SELL
$59.31 - $78.82 $244,357 - $324,738
-4,120 Reduced 12.19%
29,690 $2.08 Million
Q4 2020

Jan 08, 2021

SELL
$50.47 - $66.26 $299,135 - $392,723
-5,927 Reduced 14.92%
33,810 $2.02 Million
Q3 2020

Oct 05, 2020

BUY
$51.97 - $63.0 $519 - $630
10 Added 0.03%
39,737 $2.39 Million
Q2 2020

Jul 06, 2020

BUY
$30.8 - $52.47 $92,708 - $157,934
3,010 Added 8.2%
39,727 $2.08 Million
Q1 2020

Apr 06, 2020

BUY
$28.4 - $50.7 $147,822 - $263,893
5,205 Added 16.52%
36,717 $1.23 Million
Q4 2019

Jan 07, 2020

BUY
$36.31 - $46.83 $29,483 - $38,025
812 Added 2.64%
31,512 $1.43 Million
Q3 2019

Oct 02, 2019

BUY
$35.66 - $44.99 $1.09 Million - $1.38 Million
30,700 New
30,700 $1.17 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $946M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.